Dinesh K. Sinha
Patna, BR, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Development of a history-taking form for mesothelioma patients at risk of exposure to asbestos.
Journal: Public health action
Published: June 20, 2025
Trends and Patterns of Top Ten Common Cancers in Eastern India from 2014 to 2021: A Retrospective Hospital-based Cancer Registry Data Update.
Journal: Indian journal of community medicine : official publication of Indian Association of Preventive & Social Medicine
Published: November 27, 2023
Role of microRNA-486-5p as Biomarker Response in Cell Line K562 of Chronic Myeloid Leukemia.
Journal: Asian Pacific journal of cancer prevention : APJCP
Published: September 26, 2023
Diversity of small round cell sarcoma in soft tissues around bone among Indian patients.
Journal: Bioinformation
Published: August 01, 2023
Inclusion of patients lost to follow-up in "Kaplan-Meier" cumulative survival curves.
Journal: Journal of cancer research and therapeutics
Published: November 17, 2022
Epidemiological trends of colorectal cancer cases in young population of Eastern India: A retrospective observational study.
Journal: Journal of cancer research and therapeutics
Published: November 09, 2022
Hepatitis B in hepatocellular carcinoma patients and its correlation with alpha-fetoprotein and liver enzymes.
Journal: Journal of cancer research and therapeutics
Published: September 23, 2022
Assessment of tumor markers CA 19-9, CEA, CA 125, and CA 242 for the early diagnosis and prognosis prediction of gallbladder cancer.
Journal: World journal of gastrointestinal surgery
Published: July 13, 2022
Genomic Pattern of GSTM1 and T1 Gene Null polymorphism of Head and Neck Cancer Patients in Eastern India.
Journal: Asian Pacific journal of cancer prevention : APJCP
Published: February 08, 2022
Efficacy and tolerability of once-weekly selinexor, bortezomib, and dexamethasone in comparison with standard twice-weekly bortezomib and dexamethasone in previously treated multiple myeloma with renal impairment: Subgroup analysis from the BOSTON study.
Journal: American journal of hematology
Published: August 22, 2021
Selinexor, bortezomib, and dexamethasone versus bortezomib and dexamethasone in previously treated multiple myeloma: Outcomes by cytogenetic risk.
Journal: American journal of hematology
Published: March 22, 2021
Effect of age and frailty on the efficacy and tolerability of once-weekly selinexor, bortezomib, and dexamethasone in previously treated multiple myeloma.
Journal: American journal of hematology
Published: March 09, 2021
Last Updated: 09/26/2026